PFIZER Zaneta Phean

CIS 1055 Section 008October 1, 2012

Zaneta Phean Section 008

ABOUT PFIZER• committed to applying science and our global resources to

improve health and well-being at every stage of life• provide access to safe, effective and affordable medicines and

related health care services to the people who need them • leading portfolio of products and medicines that support wellness

and prevention • treatment and cures for diseases across a broad range of

therapeutic areas • industry-leading pipeline of promising new products that have the

potential to challenge some of the most feared diseases of our time, like Alzheimer's disease and cancer

• managed care organizations to world governments and non-governmental organizations

• goal is to ensure that people everywhere have access to innovative treatments and quality health care

Zaneta Phean Section 008

TIMELINE1849 – 1899 In 1849, cousins Charles Pfizer and Charles Erhart founded Charles Pfizer & Company in a red brick building in Brooklyn,

NY.

1900 – 1950 The new century brought prosperity to Pfizer. The pioneering of the mass production of citric acid from sugar through mold fermentation fueled growth for years.

1951 – 1999 The second half of the 1900´s saw intense pharmaceutical research and great successes for Pfizer.

2000 – Present Pfizer increases its global presence through the acquisitions of Warner-Lambert and Pharmacia. Additionally, through strategic partnerships and acquisitions of diversified

businesses, such as Wyeth, Pfizer solidifies its place as one of the most diversified companies in the global health care industry.

Pfizer continues to focus on applying science and the company's global resources to improve health and well-being at every stage

of life.

Zaneta Phean Section 008

COFOUNDERS

CHARLES PFIZER CHARLES ERHART

click arrow to meet the present Executive Leadership Team

Zaneta Phean Section 008

EXECUTIVE LEADERSHIP

TEAMIan Read

Chairman of the Board and Chief Executive Officer

Mikael DolstenPresident,

Worldwide Research & Development

Freda C. Lewis-HallExecutive Vice

President, Chief Medical Officer

Geno GermanoPresident and

General Manager, Specialty Careand Oncology

Laurie OlsonExecutive Vice

President, Strategy, Portfolio

Management and Global Commercial

Operations

Sally SusmanExecutive Vice

President, Policy, External Affairs and

Communications

Chuck HillExecutive Vice

President, Worldwide Human Resources

Kristin PeckExecutive Vice

President, Worldwide Business

Development and Innovation

John YoungPresident and

General Manager, Primary Care

Hugh DonnellyVice President, Corporate Audi

Doug LanklerExecutive Vice

President, Chief Compliance & Risk

Officer

Amy SchulmanExecutive Vice

Presidentand General Counsel; Business Unit Lead,

Consumer Healthcare;

President and General Manager,

Nutrition

Olivier BrandicourtPresident and

General Manager, Emerging Markets

and Established Products

Frank D'AmelioExecutive Vice

President, Chief Financial Officer andBusiness Operations

click arrow to go back to previous page

Zaneta Phean Section 008

PRODUCTS• Pfizer product information is intended only for residents of

the United States• Pfizer medicines help to treat and prevent a range of

conditions from the most common to the most challenging for people around the world

• Here is a list of a few Pfizer products people may be familiar with:

o Advil Brandso Centrum Brandso Chapsticko Neosporino Robitussin

Zaneta Phean Section 008

COMPETITORS• Merck & Co. Inc.• Novartis AG• Sanofi• Drug Manufacturers - Major

Zaneta Phean Section 008

RECENT NEWS• September 21, 2012  — 

Pfizer Invites Public To View And Listen To Webcast Of October 30 Conference Call With Analysts

 • September 21, 2012  — ELIQUIS® (apixaban

) Receives CHMP Positive Opinion For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation

 • September 17, 2012  — 

Pfizer Announces Data For Investigational Compound Tofacitinib In Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology 2012 Annual Meeting

 • September 17, 2012  — 

Pfizer To Present New Data in Lung And Kidney Cancers at The European Society For Medical Oncology 2012 Congress

 • September 13, 2012  — 

Pfizer and Waste Management Launch Online Pharmaceutical Disposal Guide

 • September 13, 2012  — 

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

Zaneta Phean Section 008

Zaneta Phean Section 008

FOR MORE INFORMATION• Call Us

Customer Service and Product Inquiries: 1-800-TRY-FIRST (1-800-879-3477) Monday through Friday 8:00 a.m. to 8:00 p.m. EST 

Corporate Office: 1-212-733-2323 235 East 42nd Street New York, NY 10017 

Frequently asked questions

Send Email